John D Lambris
25PUBLICATIONS
129CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (25)
Sort by Publication Date:
|Apr 04, 2025
'Complement-ing' tissue inflammation via granzyme K?Dimitrios C Mastellos, John D Lambris
|Dec 12, 2024
The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response.Yaiza Senent, Ana Remírez, David Repáraz
|Jun 12, 2023
The Complement-Targeted Inhibitor Mini-FH Protects against Experimental Periodontitis via Both C3-Dependent and C3-Independent Mechanisms.Xiaofei Li, Hui Wang, Christoph Q Schmidt
|Feb 09, 2023
Complement-targeted therapeutics: An emerging field enabled by academic drug discovery.Christina Lamers, Daniel Ricklin, John D Lambris
|Aug 17, 2022
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101.Panagiotis Skendros, Georgios Germanidis, Dimitrios C Mastellos
Pageof 5
Frequent Collaborators
7 joint publications
Dimitrios C Mastellos
6 joint publications
Daniel Ricklin
4 joint publications
George Hajishengallis
4 joint publications
Anna M Blom
3 joint publications
Tom Eirik Mollnes
3 joint publications
Trent M Woodruff
2 joint publications
Malvina Papanastasiou
2 joint publications
Taroh Kinoshita
2 joint publications
Ronald P Taylor
2 joint publications
David Ermert
